OTCMKTS:WXXWY WuXi Biologics (Cayman) (WXXWY) Stock Price, News & Analysis $13.80 -0.63 (-4.37%) As of 10/8/2026 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and TrendsShort Interest About WuXi Biologics (Cayman) Stock (OTCMKTS:WXXWY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get WXXWY alerts:Sign Up Key Stats Today's Range$13.31▼$13.9050-Day Range$9.88▼$14.7952-Week Range$7.30▼$14.80Volume114,472 shsAverage Volume70,677 shsMarket Capitalization$28.40 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview WuXi Biologics (Cayman) Inc. is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company works with pharmaceutical and biotechnology customers to support the development and production of biologic therapies, including monoclonal antibodies, recombinant proteins, vaccines and other complex biological products. Its services span early-stage discovery and cell-line development through process development, clinical manufacturing, regulatory support and commercial-scale production. WuXi Biologics also provides capabilities for newer modalities, including certain bispecific antibodies, antibody-drug conjugates, gene therapies and cell therapies, helping customers advance programs from laboratory research to market supply. The company was established in 2010 as part of WuXi AppTec and became a separately listed business in Hong Kong in 2018. WuXi Biologics serves pharmaceutical and biotechnology companies internationally through operations and facilities in China, the United States, Ireland, Germany and other locations. The company is led by Chief Executive Officer Dr. Chris Chen.AI Generated. May Contain Errors. Read More WuXi Biologics (Cayman) Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks49th Percentile Overall ScoreWXXWY MarketRank™: WuXi Biologics (Cayman) scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingWuXi Biologics (Cayman) has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageWuXi Biologics (Cayman) has only been the subject of 1 research reports in the past 90 days.Read more about WuXi Biologics (Cayman)'s stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth19.57% Earnings GrowthEarnings for WuXi Biologics (Cayman) are expected to grow by 19.57% in the coming year, from $0.46 to $0.55 per share. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of WuXi Biologics (Cayman) has been sold short.Short Interest Ratio / Days to CoverWuXi Biologics (Cayman) has a short interest ratio ("days to cover") of 0.22, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in WuXi Biologics (Cayman) has recently decreased by 20.62%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWuXi Biologics (Cayman) does not currently pay a dividend.Dividend GrowthWuXi Biologics (Cayman) does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.57 News SentimentWuXi Biologics (Cayman) has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for WuXi Biologics (Cayman) this week, compared to 1 article on an average week.Search Interest2 people have searched for WXXWY on MarketBeat in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, WuXi Biologics (Cayman) insiders have not sold or bought any company stock.Percentage Held by InstitutionsWuXi Biologics (Cayman) has minimal institutional ownership at this time.Read more about WuXi Biologics (Cayman)'s insider trading history. Receive WXXWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for WuXi Biologics (Cayman) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WXXWY Stock News HeadlinesWuXi Biologics (Cayman) (OTCMKTS:WXXWY) Reaches New 52-Week High - Time to Buy?October 6 at 11:01 AM | americanbankingnews.comWuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Down - Time to Sell?October 5, 2026 | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. | Stansberry Research (Ad)WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Shares Gap Up - Here's WhyOctober 3, 2026 | americanbankingnews.comBig Pharma Is Pouring Billions Into China's BiotechsSeptember 14, 2026 | barrons.comWuXi Biologics (Cayman) Inc. (WXXWY) Q2 2026 Earnings Call TranscriptAugust 27, 2026 | seekingalpha.comWuXi Biologics Schedules Conference Calls to Present 2026 Interim ResultsAugust 25, 2026 | tipranks.comWuXi Biologics sets August board meeting to approve interim 2026 resultsJuly 24, 2026 | tipranks.comSee More Headlines WXXWY Stock Analysis - Frequently Asked Questions How have WXXWY shares performed this year? WuXi Biologics (Cayman)'s stock was trading at $8.0950 at the beginning of 2026. Since then, WXXWY shares have increased by 70.5% and is now trading at $13.80. How do I buy shares of WuXi Biologics (Cayman)? Shares of WXXWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today10/09/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:WXXWY CIKN/A Webwww.wuxibiologics.com Phone8651081831205FaxN/AEmployees13,252Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,058,165,000Free FloatN/AMarket Cap$28.40 billion OptionableNot Optionable BetaN/A 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:WXXWY) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WuXi Biologics (Cayman) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share WuXi Biologics (Cayman) With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
